These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3295676)

  • 1. Objective changes in intrauterine pressure during placebo treatment of dysmenorrhea.
    Smith RP
    Pain; 1987 Apr; 29(1):59-66. PubMed ID: 3295676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea.
    Smith RP; Powell JR
    Am J Obstet Gynecol; 1987 Sep; 157(3):611-8. PubMed ID: 3307421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
    Henzl MR; Ortega-Herrera E; Rodriguez C; Izu A
    Am J Obstet Gynecol; 1979 Oct; 135(4):455-60. PubMed ID: 484644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The objective evaluation of dysmenorrhea therapy.
    Smith RP; Powell JR
    Am J Obstet Gynecol; 1980 Jun; 137(3):314-9. PubMed ID: 6990763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I; Hedner N; Mannheimer C
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):123-9. PubMed ID: 8296814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelation of analgesia and uterine activity in women with primary dysmenorrhea. A preliminary report.
    Smith RP; Heltzel JA
    J Reprod Med; 1991 Apr; 36(4):260-4. PubMed ID: 2072357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dynamics of nonsteroidal anti-inflammatory therapy for primary dysmenorrhea.
    Smith RP
    Obstet Gynecol; 1987 Nov; 70(5):785-8. PubMed ID: 3309752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I; Andersch B; Sundell G
    Acta Obstet Gynecol Scand; 1988; 67(8):711-6. PubMed ID: 3074603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia-related hemogram, uterine artery pulsatility index, and blood pressure for the effects of Four-Agents-Decoction (Si Wu Tang) in the treatment of primary dysmenorrhea.
    Yeh LL; Liu JY; Liu YS; Lin KS; Tsai TF; Wang LH
    J Altern Complement Med; 2009 May; 15(5):531-8. PubMed ID: 19413507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine pressure changes during dysmenorrhea therapy.
    Smith RP; Powell JR
    Am J Obstet Gynecol; 1982 Jun; 143(3):286-92. PubMed ID: 6805330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhea.
    Liedman R; Grant L; Igidbashian S; James I; McLeod A; Skillern L; Akerlund M
    Acta Obstet Gynecol Scand; 2006; 85(2):207-11. PubMed ID: 16532916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a test model of induced dysmenorrhea.
    Liedman R; Skillern L; James I; McLeod A; Grant L; Akerlund M
    Acta Obstet Gynecol Scand; 2006; 85(4):451-7. PubMed ID: 16612708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double-blind, within-patient, placebo-controlled study.
    Marchini M; Tozzi L; Bakshi R; Pistai R; Fedele L
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):491-7. PubMed ID: 8520806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal glyceryl trinitrate in the management of primary dysmenorrhea.
    Moya RA; Moisa CF; Morales F; Wynter H; Ali A; Narancio E
    Int J Gynaecol Obstet; 2000 May; 69(2):113-8. PubMed ID: 10802078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen therapy for dysmenorrhea.
    Corson SL; Bolognese RJ
    J Reprod Med; 1978 May; 20(5):246-52. PubMed ID: 353274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter studies in the United States and Canada of meclofenamate sodium in osteoarthritis of the hip and knee. Double-blind comparison with placebo and long-term experience.
    Petrick TJ; Bovenkerk WE
    Arzneimittelforschung; 1983; 33(4A):644-8. PubMed ID: 6349649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rationale for the treatment of dysmenorrhea.
    Csapo AI
    J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant, long-lasting pain relief in primary dysmenorrhea with low-dose naproxen sodium compared with acetaminophen: a double-blind, randomized, single-dose, crossover study.
    Daniels SE; Paredes-Diaz A; An R; Centofanti R; Tajaddini A
    Curr Med Res Opin; 2019 Dec; 35(12):2139-2147. PubMed ID: 31397597
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of menorrhagia with meclofenamate sodium.
    Vargyas JM; Campeau JD; Mishell DR
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):944-50. PubMed ID: 3314521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.